PT 141 (Bremelanotide)
PT-141, also known as Bremelanotide, is a synthetic cyclic heptapeptide analog of alpha-MSH that acts as a non-selective agonist of melanocortin receptors in the central nervous system. Unlike conventional sexual health medications that work through vascular mechanisms, PT-141 operates centrally through the CNS to directly enhance sexual motivation, arousal, and desire in both men and women.
PT-141 has been clinically studied and an FDA-approved version (Vyleesi) exists for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. In broader wellness and performance applications, it is used by both men and women to enhance libido, address sexual dysfunction, and improve overall sexual experience and satisfaction.
Because its mechanism is neurological rather than vascular, PT-141 is effective in individuals where PDE5 inhibitors may be insufficient or contraindicated. It is typically administered 1-2 hours before desired effect and its action can last 6-72 hours depending on dose and individual response. All use should be under medical supervision to manage dosing and monitor for potential side effects.
| Details | Information |
|---|---|
| API | Bremelanotide (PT-141) |
| Strength | 10 MG |
| Format | Lyophilised Peptide Vial |
| Category | Sexual Health / Wellness |
| Usage | Injectable or Intranasal — Reconstitute before use |
Disclaimer: Above mentioned information is for educational and reference purposes only. Consult a registered healthcare professional for a proper course of medication. These statements have not been evaluated by the Food and Drug Administration. This product shall only be available on a prescription from a registered healthcare professional.
Frequently Asked Questions
What is PT 141?
What is PT 141 commonly associated with?
How is PT 141 typically used?
Are there risks associated with PT 141?
Can PT 141 be used without medical supervision?
Is PT 141 suitable for everyone?







Reviews
There are no reviews yet.